Oncoclínicas Gets 60-Day Court Shield as It Moves to Restart Cancer Treatments

Overview

• Oncoclínicas secured a 60-day court injunction Thursday that freezes creditor lawsuits and blocks on assets.
• The São Paulo business court order also pauses the demand for certain debts during mediation, giving the company a short window to prepare an out-of-court restructuring.
• The company accepted a R$150 million loan from Mak Capital with Lumina, earmarked only to rebuild drug stocks and backed by future payments due from health plans, hospitals and insurers.
• With supplies refilling, the network said it is running a task force to call patients and restart chemotherapy, radiotherapy and immunotherapy that were postponed.
• The strain traces to a R$3.67 billion loss in 2025 and about R$3.2 billion in debt, leaving leverage at 4.3 times earnings before interest, taxes, depreciation and amortization against a 3.5-times covenant.